Celltrion Pharm Inc.(KR:068760)
₩41,300.00+1700.00 (+4.29%)
KR:068760
Celltrion Pharm Inc. financials statements
₩41,300.00
At close:+1700.00 (+4.29%)
Want to see KR:068760 full AI Analyst Report?
Celltrion Pharm Inc. (068760) Financial Statements
Celltrion Pharm Inc. Financial Overview
Celltrion Pharm Inc.'s market cap is currently ₩1.72T. The company's EPS TTM is ₩882.94; its P/E ratio is 130.86; and it has a dividend yield of 0.37%. Celltrion Pharm Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₩ 536.40B | ₩ 477.84B | ₩ 388.79B | ₩ 386.04B | ₩ 398.74B |
| Gross Profit | ₩ 163.78B | ₩ 122.01B | ₩ 119.71B | ₩ 112.77B | ₩ 119.25B |
| Operating Income | ₩ 56.09B | ₩ 37.22B | ₩ 36.07B | ₩ 38.17B | ₩ 47.80B |
| EBITDA | ₩ 78.63B | ₩ 57.36B | ₩ 54.22B | ₩ 54.10B | ₩ 64.26B |
| Net Income | ₩ 38.75B | ₩ 21.97B | ₩ 21.26B | ₩ 25.96B | ₩ 34.58B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₩ 116.93B | ₩ 69.60B | ₩ 37.13B | ₩ 49.07B | ₩ 88.16B |
| Total Assets | ₩ 759.44B | ₩ 669.46B | ₩ 641.64B | ₩ 599.72B | ₩ 637.88B |
| Total Debt | ₩ 161.31B | ₩ 172.17B | ₩ 162.53B | ₩ 160.70B | ₩ 181.03B |
| Net Debt | ₩ 111.44B | ₩ 126.69B | ₩ 142.82B | ₩ 129.31B | ₩ 100.85B |
| Total Liabilities | ₩ 323.48B | ₩ 272.54B | ₩ 264.98B | ₩ 242.94B | ₩ 305.92B |
| Stockholders' Equity | ₩ 435.96B | ₩ 396.92B | ₩ 376.67B | ₩ 356.79B | ₩ 331.97B |
| Cash Flow | |||||
| Free Cash Flow | ₩ 68.51B | ₩ 50.61B | ₩ 1.86B | ₩ -10.33B | ₩ 80.65B |
| Operating Cash Flow | ₩ 86.43B | ₩ 56.59B | ₩ 8.76B | ₩ -4.05B | ₩ 93.15B |
| Investing Cash Flow | ₩ -57.54B | ₩ -12.12B | ₩ -4.22B | ₩ -14.57B | ₩ -16.30B |
| Financing Cash Flow | ₩ -24.50B | ₩ -18.71B | ₩ -16.21B | ₩ -30.18B | ₩ -22.41B |
Currency in KRW
